Additionally, further murine studies have highlighted the protective effects of NAG-1 across various biological contexts, including renal, cardiac, and neuronal cell survival, indicating its promising therapeutic potential for conditions such as kidney injury, myocardial infarction, and Parkinson’s disease [37–39]. This evidence concerns the gene GDF15 and Parkinson disease.